Monday Action for Firm Using AI in Drug Discovery for Malaria Treatment

By: Tomas Ronolski - AllPennyStocks.com News

Monday, January 13, 2025

AI is being used across industries, and its role in drug discovery is pivotal as pharmaceutical companies seek to accelerate the development of new treatments for diseases like malaria and HIV. Through its strategic investment target this company supports the development of cutting-edge AI-powered healthcare solutions.

1606 Corp. (OTC Pink:CBDW) announced in a press release today its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's groundbreaking announcement of Trapicolast. This drug is a pioneering antimalarial drug developed through its innovative AI-powered Sutra™ platform and marks a significant advancement in the fight against malaria, particularly in regions with rising drug resistance.

Trapicolast introduces a novel and highly effective treatment for malaria by focusing on the apicoplast. By targeting its DNA synthesis and vesicular trafficking pathways, Trapicolast disrupts the parasite's ability to survive and reproduce, providing a robust defense against drug-resistant malaria strains.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Unlocking Hidden Diamond Potential in Chile

U.S. Budget Deficit Soars in First Fiscal Quarter

MicroCap Trading Higher As Major Stakeholder Plans to Acquire Up to 10% of Common Shares

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Monday Action for Firm Using AI in Drug Discovery for Malaria Treatment

Unlocking Hidden Diamond Potential in Chile

Capital One Customers Complain of Being Locked Out of Accounts

TikTok to ‘Go Dark’ on Sunday for Its 170 Million American Users

AllPennyStocks.com Favorites

Creator Commerce Meets Premium Wines in Strategic Merger

Enable Free Access to Unlock Up to Two Articles Per Month.

Equities Rally on Earnings, Positive Inflation Print

Enable Free Access to Unlock Up to Two Articles Per Month.

Friday's technical standout looks to be Graphene Manufacturing Gr, which is displaying a Golden Cross (50 DMA / 200 DMA) with today’s move to $0.51.

TSX-Venture listed, Amarc Resources Ltd. was a standout in Friday's trade. The stock popped 171.70%, closing out the day at $0.72.

Friday's largest penny Stock gainer on the OTC Markets was Amarc Resources Ltd., which rallied 169.02%, closing at $0.50.

This Renewable Energy Stock Could Be A Massive Outperformer

Enable Free Access to Unlock Up to Two Articles Per Month.

This Chinese Stock Could Massively Outperform In Q1

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●"By The Numbers" Data Analytics

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2025 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

Monday Action for Firm Using AI in Drug Discovery for Malaria Treatment

Other Penny Stock Movers

Unlocking Hidden Diamond Potential in Chile

U.S. Budget Deficit Soars in First Fiscal Quarter

MicroCap Trading Higher As Major Stakeholder Plans to Acquire Up to 10% of Common Shares

Most Popular

AllPennyStocks.com Favorites